医学
缺血性中风
冲程(发动机)
危险分层
重症监护医学
专家意见
精密医学
内科学
病理
缺血
机械工程
工程类
作者
Giulio Bicciato,Markus Arnold,Aidan Gebhardt,Mira Katan
标识
DOI:10.1097/wco.0000000000001011
摘要
Purpose of review One in eight patients unfortunately suffers a new stroke within 5 years of their first stroke, even today. Research in precision medicine could lead to a more individualized treatment allocation, possibly achieving lower recurrence rates of ischemic stroke. In this narrative review, we aim to discuss potential clinical implementation of several promising candidate blood biomarkers. Recent findings We discuss specifically some promising blood-based biomarkers, which may improve the identification of underlying causes as well as risk stratification of patients according to their specific cerebrovascular risk factor pattern. Summary Multimodal profiling of ischemic stroke patients by means of blood biomarkers, in addition to established clinical and neuroradiological data, may allow in the future a refinement of decision algorithms for treatment allocation in secondary ischemic stroke prevention.
科研通智能强力驱动
Strongly Powered by AbleSci AI